Fundraising FoxR7 Partners — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Cascade Bio develops enzyme immobilization technology ("Body Armor"), a silica-based coating applied to glass-bead supports that stabilizes enzymes so they last longer and tolerate harsher conditions than other cell-free solutions.
BiotechCleantechClimate TechDeep TechNew MaterialsDenver, US
James Weltz(Executive Officer, Director, Promoter)inAlex Rosay(Co-founder)in
BoardJared Campbell(Director)
Co-investors1Flourish CapitalAmplify.LACool Climate CollectiveEndurance28Range VCSpacecadet Ventures+4 more
Future Fields uses fruit flies as bioreactors to produce difficult-to-express proteins at scale for pharmaceutical, agricultural, and food applications.
AgTechBiotechCircular EconomyClimate TechDeep TechFoodTechHealthtechEdmonton, CA
Matt Anderson-Baron(Founder)inJalene Anderson-Baron(Founder)inLejjy Gafour
Co-investorsAgFunderAmplify CapitalBDC Climate Tech Fund IIBee PartnersBoxOne VenturesEdmonton Unlimited+13 more
Moddule builds an intelligence layer that sits above existing logistics systems (TMS, WMS, ERP, and tracking tools), unifying and normalizing carrier data, trust-scoring ETA predictions, and automatically triggering coordinated actions within human-defined guardrails.
AI & Machine LearningLogistics & Supply ChainSaaSEdmonds, US
Hans Elmegaard(Executive Officer, Director)in
Co-investorsArgon VenturesIncisive VenturesArgonautic VenturesCompanyon VenturesMotion VenturesSignal Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.